Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients

Acta Neurologica Scandinavica

Volumn 120, Issue 6, 2009, Pages 430-435

  Ahram, M ^a   El Omar, A ^b   Baho, Y ^c   Lubad, M A ^a  

^a MUTAH UNIVERSITY   (Jordan)

^b Bashir Hospital   (Jordan)

^c UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Human herpesvirus 6; Multiple sclerosis; Nested PCR

Indexed keywords

BETA GLOBIN; VIRUS DNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN HERPESVIRUS 6; JORDAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SERUM; VIRUS DETECTION;

ADULT; DNA, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; JORDAN; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION;

EID: 72849106875     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01187.x     Document Type: Article

References (45)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000 343 : 938 52.
2. Sadovnick AD, Armstrong H, Rice GP et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993 33 : 281 5.
3. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988 29 : 533 41.
4. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993 6 : 382 427.
5. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol 2000 2 : S134 40.
6. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995 47 : 425 48.
7. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin 1996 14 : 291 308.
8. Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol 2005 4 : 195 202.
9. Clark DA. Human herpesvirus 6. Rev Med Virol 2000 10 : 155 73.
10. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 2002 76 : 6147 54.
11. Opsahl ML, Kennedy PG. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005 128 : 516 27.
12. Challoner PB, Smith KT, Parker JD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995 92 : 7440 44.
13. Soldan S, Berti R, Salem N et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM responses to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997 3 : 1394 7.
14. Friedman JE, Lyons MJ, Cu G et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999 5 : 355 62.
15. Virtanen JO, Zabriskie JB, Siren V et al. Co-localization of human herpesvirus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med Sci Monit 2005 11 : BR84 7.
16. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y. Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006 253 : 1210 6.
17. El-Salem K, Khader Y. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population. Clin Neurol Neurosurg 2007 109 : 32 7.
18. Kurtzke JF. Multiple sclerosis: changing times. Neuroepidemiology 1991 10 : 1 8.
19. Secchiero P, Carrigan DR, Asano Y et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995 171 : 273 80.
20. Klee L, Zand R. Probable epitopes: relationships between myelin basic protein antigenic determinants and viral and bacterial proteins. Neuroinformatics 2004 2 : 59 70.
21. Westall FC. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 2006 44 : 2099 104.
22. Lang HL, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002 3 : 940 3.
23. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973 2 : 1221 5.
24. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004 55 : 458 68.
25. Kong H, Baerbig Q, Duncan L, Shepel N, Mayne M. Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death. J Neurovirol 2003 9 : 539 50.
26. Bech E, Lycke J, Gadeberg P et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpesvirus therapy in MS. Neurology 2002 58 : 31 6.
27. Mao YS, Lu CZ, Wang X, Xiao BG. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Exp Neurol 2007 206 : 231 9.
28. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 1996 2 : 249 58.
29. Berti R, Brennan MB, Soldan SS et al. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 2002 8 : 250 6.
30. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 2003 69 : 111 7.
31. Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler 2002 8 : 237 42.
32. Alvarez-Lafuente R, De Las Heras V, Bartolome M, Picazo JJ, Arroyo R. Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission. Eur Neurol 2004 52 : 87 91.
33. Martin C, Enbom M, Söderström M et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997 95 : 280 3.
34. Al-Shammari S, Nelson RF, Voevodin A. HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait. Acta Neurol Scand 2003 107 : 122 4.
35. Akhyani N, Berti R, Brennan MB et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000 182 : 1321 32.
36. Watzinger F, Ebner K, Lion T. Detection and monitoring of virus infections by real-time PCR. Mol Aspects Med 2006 27 : 254 98.
37. Lucchinetti CF, Brueck W, Rodriguez M, Lassmann H. Multiple sclerosis: lessons from neuropathology. Semin Neurol 1998 18 : 337 49.
38. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 47 : 707 17.
39. Lassmann H. Neuropathology in multiple sclerosis: new concepts. Mult Scler 1998 4 : 93 8.
40. Haahr S, Höllsberg P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 2006 16 : 297 310.
41. Stürzebecher S, Wandinger KP, Rosenwald A et al. Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain 2003 126 : 1419 29.
42. Martínez A, Alvarez-Lafuente R, Mas A et al. Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA. Hum Immunol 2007 68 : 685 9.
43. Munch M, Hvas J, Christensen T, Møller-Larsen A, Haahr S. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 1998 98 : 395 9.
44. Lindsey JW, Patel S, Zou J. Epstein-Barr virus genotypes in multiple sclerosis. Acta Neurol Scand 2008 117 : 141 4.
45. Gold R, Hartung HP. Towards individualised multiple-sclerosis therapy. Lancet Neurol 2005 4 : 693 4.